Toronto, Ontario–(Newsfile Corp. – August 14, 2023) – Sensor Technologies Corp. (CSE: SENS) (the “Company” or “Sensor”) announces that Ms. Maria Diaz has resigned as a director of Sensor. The Company would like to wish Ms. Diaz success in her future endeavors.
Mr. Brian Grieve has been appointed director of Sensor. Mr. Grieve is an experienced IT professional and the founder and Chief Technology Officer of Cloudpipe Inc., a “technology-centric” consulting firm specialized in helping organizations achieve excellence in software quality assurance and software development by applying its thought leadership, a dedicated workforce, and innovative technology solutions. Mr. Grieve has over 30 years of proven expertise in systems analysis, showcasing an unparalleled ability to unravel intricate technical and operational challenges swiftly. He possesses a Master of Business Administration from MIT Sloan School of Management, specializing in Artificial Intelligence and Business Strategy, a Bachelor of Commerce, Information Technology and a Bachelor of Applied Science (B.A.Sc.) in Computer Science with a minor in Physics.
Corporation contact:
Jay Vieira, President, CEO
email: jay@fox-tek.com
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/177064
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…